Summary
Viruses are obligate parasites known to interact with a wide variety of host proteins at different stages of infection. Current antiviral treatments target viral proteins and may be compromised due to the emergence of drug resistant viral strains. Targeting viral‐host interactions is now gaining recognition as an alternative approach against viral infections. Recent research has revealed that heterogeneous ribonucleoprotein A1, an RNA‐binding protein, plays an essential functional and regulatory role in the life cycle of many viruses. In this review, we summarize the interactions between heterogeneous ribonucleoprotein A1 (hnRNPA1) and multiple viral proteins during the life cycle of RNA and DNA viruses. hnRNPA1 protein levels are modulated differently, in different viruses, which further dictates its stability, function, and intracellular localization. Multiple reports have emphasized that in Sindbis virus, enteroviruses, porcine endemic diarrhea virus, and rhinovirus infection, hnRNPA1 enhances viral replication and survival. However, in others like hepatitis C virus and human T‐cell lymphotropic virus, it exerts a protective response. The involvement of hnRNPA1 in viral infections highlights its importance as a central regulator of host and viral gene expression. Understanding the nature of these interactions will increase our understanding of specific viral infections and pathogenesis and eventually aid in the development of novel and robust antiviral intervention strategies.
Keywords: heterogeneous ribonucleoprotein A1, hnRNPA1, replication, RNA binding proteins, role, viruses
Abbreviations
- ARV
avian reovirus
- CRE
cis‐acting replication element
- ds
double‐stranded
- EBV
Epstein‐Barr virus
- ESS 2
exonic splicing silencer 2
- EV‐71
enterovirus 71
- G and SG RNA
genomic and sub genomic RNA
- HCV
hepatitis C virus
- HIV‐1
human immunodeficiency virus 1
- HK‐2
hexokinase 2
- hnRNAs
heterogeneous nuclear RNAs
- hnRNP
heterogeneous nuclear ribonucleoprotein
- hnRNPA1
heterogeneous ribonucleoprotein A1
- HPV‐16
human papillomavirus 16
- HRV
human rhinovirus
- HTLV‐1
human T‐cell lymphotropic virus type 1
- IG sequence
intergenic sequence
- IR‐1
internal repeat region 1
- IRES
internal ribosome entry site
- ITAF
internal trans activating factor
- JUNV
Junin virus
- LMP‐2
latent membrane protein 2
- LTR
long terminal repeat
- MAPKs
Mitogen‐activated protein kinases
- MHV
murine hepatitis virus
- mRNAs
messenger RNAs
- N
nucleocapsid protein
- NLS
Nuclear localization sequence
- ORF
open reading frame
- PEDV
porcine epidemic diarrhea virus
- PKC
Protein kinase C
- PTMs
Post translational modifications
- RBDs
RNA‐binding domains
- RBPs
RNA‐binding proteins
- RGG
Arginine‐glycine‐glycine
- RIPs
RNA immunoprecipitations
- RNAi
RNA interference
- RRMs
RNA Recognition motifs
- RxRE or XRE
rex response element
- S6Ks
Ribosomal S6 kinases
- SARS CoV
severe acute respiratory syndrome coronavirus
- siRNA
silencing RNA
- SL‐II
stem loop II
- UTR
untranslated region
- VSV
vesicular stomatitis virus
- Y2H
Yeast two‐hybrid screens
- (GlcNAc)
O‐GlcNAcylation (GlcNAc)
1. INTRODUCTION
Viruses, despite their limited number of genes, utilize many host factors for efficient replication in the host.1 Depending on the nature of their genetic material, viral proteins interact with a plethora of host proteins that facilitate their infection inside the infected host.2, 3, 4, 5, 6 Host cellular systems comprise highly complicated and sophisticated networks that consist of interactions between numerous cellular components; viruses hijack these cellular pathways, leading to the reconstruction of modulated networks to meet their requirements for efficient replication and immune suppression.7, 8, 9, 10, 11
Recent technical advances in methodology, including genome‐wide RNA interference (RNAi) screens, yeast two‐hybrid (Y2H) screens, and transcriptional gene expression profiling, have identified hundreds of host proteins involved in viral infections, of which about one in five are RNA‐binding proteins (RBPs).11, 12, 13, 14, 15 The multifaceted role of the host RNA machinery means that RBPs are at the center of host‐virus cross‐talk. However, a comprehensive understanding of the sizeable network of host proteins interacting with the viral machinery still remains to be elucidated.
The transcripts of protein‐coding genes in the nucleus of eukaryotic cells are known as heterogeneous nuclear RNAs (hnRNAs). After being transcribed, cellular pre‐mRNAs associate with nuclear proteins to form heterogeneous nuclear ribonucleoprotein (hnRNP) complexes, which function to affect the structure, posttranscriptional processing, or nucleocytoplasmic transport of these mRNAs.16, 17 They also regulate splicing, nuclear export of mRNAs, telomere biogenesis, DNA repair, transcription, translation, and cell signalling.17, 18, 19 The hnRNP family comprises of more than 20 evolutionarily conserved proteins, named alphabetically from hnRNPA1‐hnRNPU in humans.17 All the members of the family share a common modular structure consisting of one or more RNA‐binding domains (RBDs) which dictate their interaction with RNA.17
hnRNPA1 is the most abundant RBP in the hnRNP(A/B) subfamily. It affects the expression of many critical genes in the host, at the transcriptional, posttranscriptional, translational, and post‐translational level which are responsible for controlling crucial metabolic pathways in the host.19, 20, 21, 22 The N‐terminal domain of the protein encodes two RBDs which are pivotal for RNA specificity and binding (Figure 1). Additionally, a flexible glycine‐rich arginine‐glycine‐glycine (RGG) region known as the RGG box imparts protein and RNA binding features to the protein. Downstream of the RGG box, there is a 38 amino acid (aa) sequence termed the M9 nuclear localisation sequence (NLS) in the glycine (Glyc) rich region, which facilitates bidirectional nucleo‐cytoplasmic shuttling of the protein by means of its interaction with the members of importin α/β sub‐family17, 23, 24, 25 (Figure 1). Transportin‐1 interacts with the Glyc‐rich region (195‐268 aa) of hnRNPA1 by the virtue of its F‐peptide (301‐318 aa).25
Figure 1.

Structural and functional features of heterogeneous ribonucleoprotein (hnRNPA1). hnRNPA1 has two different isoforms (A1‐A, 372 AMino acids; A1‐B, 320 AMino acids). N‐terminal domain imparts the RNA recognition and specificity to the protein by RNA recognition motifs (RRM 1, RRM 2) while C terminal domain comprises of arginine‐glycine‐glycine (RGG) region and M9; nuclear localisation sequence (NLS) that dictates the sub‐cellular localisation of the protein
Post‐translation modifications (PTMs) in a protein are known to affect their activity and binding affinity. Likewise, several post‐translational modifications like phosphorylation, methylation, ubiquitination, and sumoylation dictate the activity and compartmentalization of hnRNPA1 in a cell.17 For instance, methylation of arginine residues in the RGG motif may regulate the RNA‐binding activity of the protein.21, 26, 27, 28 Similarly, kinases such as protein kinase C (PKC), mitogen‐activated protein kinases (MAPKs), and ribosomal S6 kinases (S6Ks) phosphorylate serine residues present at both the N and C terminal of the protein, regulating its function.17, 21, 29, 30, 31 PTMs like phosphorylation in the C‐terminal region of the protein result in cytoplasmic accumulation of hnRNPA1.22, 25, 30 Contrastingly, the addition of O‐GlcNAcylation (GlcNAc) moiety to the serine or threonine aa via β‐O‐linkage is a commonly occurring, reversible modification which impairs the binding of hnRNPA1 to karyopherin β (Transportin‐1).25, 32 This leads to enhanced nuclear localization of the protein, eventually affecting its activity.25
2. MULTIPLE ROLES OF hnRNPA1 IN VIRUSES
Based on the polarity of the genome, viruses are categorized as positive sense or negative sense. Depending on their genetic makeup, they need to utilize many RBPs to successfully complete their infection cycle in the host.33, 34, 35 As the replication of the viral genome takes place in the host cytoplasm or nucleus, they must have a mechanism in place to discriminate between the cellular and viral RNAs present in an infected cell. Moreover, due to their limited coding capacity, they lack preexisting RNA machinery to ensure successful replication in the host. Owing to all these factors, viruses have strategically evolved to exploit host RNA‐binding proteome and evade host RNA degradation mechanisms. hnRNPA1 is an RBP involved at multiple stages post‐infection that, depending on the virus in question, has contradictory roles; in some, it promotes viral replication, while in others, it abrogates it. Diverse roles exhibited by the protein are summarized below (Tables 1, 2, 3, 4).
Table 1.
Summary of reports showing hnRNPA1 as an antiviral host protein
| Serial Number | Virus | Genome Type | Cytoplasmic Retention | Functional Implication |
|---|---|---|---|---|
| 1 | Human T‐cell lymphotropic virus (HTLV‐1)28, 36 | RNA virus (+) | ‐ |
|
| 2 | RNA virus (+) | ‐ |
|
Table 2.
Summary of reports showing hnRNPA1 as a pro‐viral host protein
| Serial Number | Virus | Genome Type | Cytoplasmic Retention | Functional Implication |
|---|---|---|---|---|
| 1 | Sindbis virus18, 37 |
RNA virus (+) |
‐ |
|
| 2 | Epidemic Porcine Diarrhea virus (PEDV)38 |
RNA virus (+) |
‐ |
|
| 3 | Enterovirus 71 (EV‐71)39 | RNA virus (+) | ‐ |
|
| 4 | Human rhinovirus (HRV)40, 41 |
RNA virus (+) |
Yes |
|
| 5 | Avian reovirus (ARV)42 | ds RNA virus | ‐ |
|
Table 3.
Summary of reports with contradicting roles for hnRNPA1
| Serial Number | Virus | Genome Type | Cytoplasmic Retention | Functional Implication |
|---|---|---|---|---|
| 1 |
RNA virus (+) |
Yes |
|
|
| 2 | SARS corona virus (SARS CoV)47, 48 | RNA virus (+) | ‐ |
|
| 3 | Murine Hepatitis virus (MHV)49, 50 | RNA virus (+) | ‐ |
|
| 4 | Junin virus (JUNV)51 |
RNA virus (−) |
Yes |
|
Table 4.
Summary of reports in which the role of hnRNPA1 is not elucidated
| Serial Number | Virus | Genome Type | Cytoplasmic Retention | Functional Implication |
|---|---|---|---|---|
| 1 |
Epstein‐Barr virus (EBV)52 |
RNA virus (+) |
‐ |
|
| 2 | Human papilloma virus −16 (HPV‐16)44, 53 | DNA virus | ‐ |
|
| 3 |
Vesicular stomatitis virus (VSV)54 |
RNA virus (−) | ‐ |
|
2.1. Antiviral role of hnRNPA1
By the virtue of advanced techniques like RNAi screen, microarray, forward chemical genetics, proteomic, Y2H screens, and RNA immunoprecipitations (RIPs), the association of hnRNPA1 with multiple promoters, untranslated (UTR) regions, and participation at various stages of viral gene expression has been elucidated (Figure 2).2, 10, 15, 55, 56, 57, 58 Upon infection of cells by viruses, the genome acts as a template for viral gene transcription and posttranscriptional regulation, thereby facilitating the expression of viral genes.
Figure 2.

Functional role of heterogeneous ribonucleoprotein A1 (hnRNPA1) in viral infections. hnRNPA1 is targeted by viruses to control various stages in their life cycle: (A) replication, (B) transcription, (C) posttranscriptional modification like nuclear export/import, and (D) translation
In human T‐cell lymphotropic virus type I (HTLV‐1) cell culture model, hnRNPA1 inhibits the binding of the Rex protein to its response element (RxRE or XRE) in 3′ long terminal repeat (LTR) of all viral RNAs. Silencing RNA (siRNA)–mediated knockdown of hnRNPA1 affected the splicing of gag/pol transcripts and increased the binding of Rex to its response element, thereby positively affecting the rate of viral replication.36 Furthermore, ectopic expression of hnRNPA1 antagonized the posttranscriptional activity of Rex by competitive binding, thereby eliciting an antiviral response against HTLV‐1 infection.59
Hepatitis C virus (HCV) has a 13.6‐kb genome which encodes a single positive sense RNA molecule 9.6 kb in size encoding a polycistronic open reading frame (ORF) flanked by UTR regions at the 5′ and 3′ ends.60, 61, 62, 63 These regions are pivotal for viral replication. The conserved region at the 3′ end of the ORF is termed the cis‐acting replication element (CRE), which is indispensable for viral replication and translation. The conserved structure is responsible for RNA‐RNA interactions with various viral and host factors, one of which is hnRNPA1.26, 29, 64, 65, 66, 67, 68 Additionally, viral RNA‐dependent RNA polymerase (NS5B) also interacts with hnRNPA1.58, 65 Up‐regulation of hnRNPA1 in Huh‐7 cells, down‐regulated HCV RNA synthesis, and 48 hours post‐infection coinciding with a surge in HCV RNA synthesis were observed after hnRNPA1 silencing.60 The authors speculate that since hnRNPA1 binds to both the CRE and viral polymerase, it might compete with the latter, for efficient viral replication thereby exerting an antiviral effect.60 Viruses in which hnRNPA1 plays an antiviral role are summarized below (Table 1).
2.2. Pro‐viral role of hnRNPA1
Pro‐viral effect was seen in Sindbis virus infection model, wherein hnRNPA1 was redistributed to the cytoplasmic site of viral replication and bound to the 5′ UTR region (5′UTR) of viral RNA, promoting the synthesis of negative‐strand RNA (G and SG RNA). Furthermore, a decline in hnRNPA1 expression affected viral RNA synthesis, cap‐dependent and cap‐independent translation of viral genes.37, 69
A similar trend was reported in porcine epidemic diarrhea virus (PEDV) infection, wherein hnRNPA1 co‐immunoprecipitated with PEDV nucleocapsid protein (N) during the course of infection.38 Furthermore, hnRNPA1 also bound to terminal leader sequence and intergenic (IG) sequence important for efficient virus replication.35, 62
Levengood et al reported that in enterovirus 71 (EV‐71) infection, hnRNPA1 is redistributed to the cytoplasm and interacts with the 5′UTR in the stem loop II (SL‐II) region of the internal ribosome entry site (IRES) v‐ RNA (viral RNA), thereby acting as an internal trans activating factor (ITAF), accentuating IRES‐mediated translation of viral genes.39 Combined knockdown of hnRNPA1 and hnRNPA2B1 greatly impaired viral RNA translation, impeding viral replication.70, 71 Biophysical studies also showed that the SL‐II domain undergoes a conformational change to assemble a viable hnRNPA1‐RNA complex. Mutations or deletions in this region completely impair viral replication.39
Cammas et al reported physical binding of hnRNPA1 to the 5′UTR region of human rhinovirus (HRV) IRES.40 Courteau et al supported this and also showed that cytoplasmic localization of hnRNPA1 controlled and enhanced IRES‐mediated translation of viral proteins, thereby acting as an ITAF.41 Furthermore, down‐regulating hnRNPA1 or expressing a cytoplasmic restricted mutant of the protein (hnRNPA1 ΔM9) partially restored the block on viral translation.41 They also identified the role of hexokinase 2 (HK‐2) in controlling the nucleo‐cytoplasmic distribution of hnRNPA1.41
Chiu et al reported that in avian reovirus (ARV) infection, nonstructural protein p17 is shuttled to and fro from the nucleus in an hnRNPA1‐dependent manner.42 hnRNPA1 is constantly shuttled to and fro the nucleus by an active import/export mechanism which relies on its interaction with the F‐peptide (301‐318 aa) of Transportin‐1, a member of the importin family.23, 24, 25, 72, 73 ARV p17 protein interacts with hnRNPA1 and is indirectly shuttled across the nuclear pore complex, alongside the hnRNPA1‐transportin‐1 cargo.42 C‐terminal, glycine‐rich region (195‐268 aa) of hnRNPA1 is deemed crucial for its interaction with ARV p17 (19‐40 aa).42 This is supported by site‐directed mutagenesis, wherein mutant hnRNPA1195‐268 with intact M9 NLS (195‐268 aa) retained its binding ability to p17, whereas mutant hnRNPA11‐184 (1‐184 aa) lost its capacity to interact with p17, thereby leading to the nuclear accumulation of ARV p17 protein.42 Multiple reports suggest that ARV p17 protein induces autophagy that is mandatory to support efficient replication in the host.74, 75, 76 The authors suggest that ARV p17‐hnRNPA1 interaction is needed for import and export of the p‐17 cargo via the nuclear pore complex (NPC). Additionally, siRNA‐mediated knockdown of hnRNPA1 in p17 transfected Vero cells exhibited nuclear retention of p17, 17 to 30 hours posttransfection.42 Furthermore, siRNA‐mediated depletion of hnRNPA1 in Vero cells dropped ARV titer, establishing that hnRNPA1 plays a pro‐viral role in ARV infection.42
Various viruses in which hnRNPA1 supports viral replication in the host are listed in Table 2.
2.3. Controversial role of hnRNPA1
In the case of human immunodeficiency virus 1 (HIV‐1) infection, contradictory results were reported by two different research groups, Monette et al reported a surge in the amount of endogenously expressed hnRNPA1 post‐HIV‐1 infection, as enhanced hnRNPA1 levels were seen to be favorable for the virus.43 Additionally, HIV v‐RNA was immunoprecipitated with hnRNPA1 protein.43, 77 A decrease in hnRNPA1 levels down‐regulated viral pr55Gag expression, affecting viral replication negatively.43, 53 Subsequently, a virus‐imposed block on hnRNPA1 import to the nucleus was observed. This phenomenon was linked with decrease in the nuclear pore glycoprotein p62 and transportin‐1 levels, post‐infection, pivotal for nucleo‐cytoplasmic shuttling of hnRNP proteins.43 Cytoplasmic retention of hnRNPA1 favored IRES‐mediated translation of viral genes and vice‐versa.
In contrast, Zahler et al highlighted the importance of hnRNPA1 in regulating the splicing of many viral genes (viz, Tat), wherein, hnRNPA1 binds to exonic splicing silencer 2 (ESS 2), thereby repressing the splicing of Tat mRNA.44, 45 Overexpression of hnRNPA1 in an in vitro system abrogated the expression of TaT, adversely affecting viral replication.43, 45, 46, 78, 79, 80
hnRNPA1 is known for its action as a cis‐acting element favoring replication and transcription of viral genes. Luo et al reported that the C terminal region of hnRNPA1 has high affinity and directly binds to the SARS_N (Nucleopcapsid protein) in severe acute respiratory syndrome coronavirus infection (SARS CoV).81 However, a deletion in the C‐terminal region of the protein substantially abrogated viral replication and transcription, suggesting that hnRNPA1 and SARS_N interaction facilitates the binding of other cis‐ or trans‐activating factors, enabling viral transcription and replication to ensue.81
Murine hepatitis virus (MHV) belongs to the genus Betacoronaviruses. hnRNPA1 is up‐regulated and localized to the cytoplasm, post‐MHV infection.81 It regulates discontinuous viral transcription by binding to negative strand leader and IG sequence indispensable for viral transcription and also mediates the formation of MHV viral ribonucleoprotein complexes.82, 83 Furthermore, it also binds to MHV N protein which has multifarious roles in the viral life‐cycle and has the ability to bind viral RNA.16, 84, 85, 86 Remarkably, hnRNPA1 also binds to positive stranded 3′UTR, suggesting a possible role in negative strand RNA synthesis.84 There are conflicting reports about the importance of hnRNPA1 in MHV infection. According to a study by Shi et al, viral RNA synthesis was enhanced after ectopic expression of hnRNPA1; however, a truncation mutant of the protein, lacking the C terminal region responsible for cytoplasmic localization of the protein, had inverse effects.83, 87 Another report by Shen et al claimed that CB3 cell lines lacking any detectable expression of the RBP could sustain viral replication, implying that the effect exerted by hnRNPA1 can be substituted by other cellular gene products similar in function to hnRNPA1 in un‐infected and virally infected CB3 cells.49, 88 Many members of the hnRNP family interact in a similar fashion with MHV RNA viz a viz, hnRNP(A/B), hnRNPA2/B1, and hnRNPA3, further supporting the effect observed in hnRNPA1‐silenced cell line.50
Maeto et al ascribed that hnRNP A/B subfamily (hnRNP A1 and A2) has a different role in acute and persistent Junin virus (JUNV) infections.51 JUNV is a single‐stranded, enveloped RNA virus belonging to the Arenaviridae family.57, 89 Acute infection by this virus is characterized by enhanced production of viral progeny, whereas, in persistent infection, there is no infectious viral particle produced.90, 91 In acute infection, where there is production of viral nucleoprotein (N), hnRNPA1 is overexpressed and cytoplasm localized. This might aid the virus in translation. During persistent infection, hnRNPA1 was predominantly nuclear, supported by experiments using a mutant lacking NLS, as reported by Maeto et al.51, 90, 91 This difference may be linked to the role of this protein in the host whereby cytoplasmic hnRNPA1 negatively regulates the translation of anti‐apoptotic proteins like XIAP and APAF1.92, 93 Furthermore, down‐regulation of hnRNP(A/B) proteins individually abrogates JUNV replication; however, the effect was much more pronounced when both hnRNPA1 and hnRNPA2 were silenced simultaneously.51 Moreover, hnRNPA1 was found to co‐immunoprecipitate with N protein in acutely infected cells.51 Upregulating N protein induced cytoplasmic re‐localization of hnRNPA1 in Vero cells,51 further pointing towards the role of hnRNPA1 in the JUNV lifecycle.
2.4. Undesignated role for hnRNPA1
In Epstein‐Barr virus (EBV) infection, hnRNPA1 has been speculated to regulate the splicing of latent membrane protein 2 (LMP‐2) mRNA by its interaction with the intronic region in the LMP2 mRNA in association with hnRNPU and beta actin.52 In silico prediction studies using RBPMap identified the binding of hnRNPA1 to stabilize a noncoding internal repeat region 1 (IR1) of EBV RNA.52, 94 Additional molecular and biochemical studies aiming towards characterizing the role of this protein in EBV are needed to better understand the importance of hnRNPA1 in the EBV lifecycle.
Human papillomavirus 16 (HPV‐16) is the most common sexually transmitted virus. It encodes early and late genes under the control of different promoters. Viral gene expression is regulated at the transcriptional and posttranscriptional level.95 hnRNPA1 expression is upregulated in HPV‐16 infection.96 hnRNPA1 has also been observed to directly bind to splicing silencer RNA elements in HPV‐16L1 coding region, thereby inhibiting splicing of HPV‐16 late mRNA.97, 98, 99 Additionally, hnRNPA1 promoted splicing of early HPV mRNAs, thereby promoting enhanced gene expression.95, 100 However, further studies directing towards modulating the levels of hnRNPA1 are needed to elucidate its role in HPV‐16 replication.
In the case of vesicular stomatitis virus (VSV), Lyses et al reported that although hnRNPA1 silencing did not have any major effect on viral replication and growth, HeLa cells in which hnRNPA1 was silenced displayed delayed onset of apoptosis post‐virus infection, suggesting that hnRNPA1 may play a protective role by initiating antiviral immune response post‐VSV infection.54
3. CONCLUSION AND FUTURE DIRECTIONS
Viruses are known to usurp many host cell proteins for their own benefit.1 Successful infection is characterized by sequestering host proteins, concurrently, evading the host‐induced immune response.1 Owing to their limited genetic capacity, viruses tend to utilize many host proteins. Likewise, hosts have evolved innate and adaptive cellular defense mechanisms to counteract the infection caused by these viruses. The multifaceted nature of hnRNPA1 in the host makes it a lucrative target for many viruses. This review highlights the importance of hnRNPA1 and diverse roles played by this protein in the life cycle of various viruses.
For instance, in Sindbis virus,18, 37, 69 PEDV,38 EV‐71,39 and HRV40, 41 infections, hnRNPA1 shows a pro‐viral effect which may be attributed to the role of this protein as an ITAF, positively regulating IRES mediated translation of viral RNAs. Likewise, in ARV infection, virus exploits the nucleo‐cytoplasmic machinery in place for trafficking hnRNPA1 via its interaction with transportin‐1 to indirectly translocate p1742, 76 through the NPC. hnRNPA1 down‐regulation, affects virus titer, negatively, implicating towards a supportive role in ARV infection.42 Contrastingly, in HTLV‐136, 59 and HCV‐155, 58, 61, 63 life cycle, hnRNPA1 negatively regulates viral replication by controlling the posttranscriptional and translational modification of viral mRNAs. However, in the case of HIV‐1,43, 44, 45, 46 SARS CoV,47, 48 MHV,49, 50 and JUNV51, 89, 90, 91 infections, the advantage gained by the virus through its interaction with hnRNPA1 is debatable. This can be linked to the way the host interactome is shaped post‐viral infection. For example, depending on the stage of infection, that is, acute or chronic, the localization of hnRNPA1 is modulated and varied effects are exhibited in JUNV cell culture model.51
RBPs have been established as cis‐ and trans‐acting elements, hnRNPA1 acts as a cis‐acting element in SARS CoV infection model, controlling viral gene expression.81 It also binds SARS nucleocapsid protein, facilitating the binding of other cis‐ or trans‐activating factors, to ensure viral transcription and replication.81 In MHV infection, hnRNPA1 binds to positive and negative viral RNA.82, 83, 84 However, the role of hnRNPA1 in MHV infection is controversial. Viral replication was enhanced post‐hnRNPA1 transfection, but in hnRNPA1 silenced cell lines, no retardation in viral replication was observed,49, 83, 87, 88 indicating that the effect incurred may be substituted by other isoforms or members of hnRNP family.
In EBV and HPV‐16 infections, although hnRNPA1 has been reported to bind to viral RNA,52, 94, 97, 98, 99 further studies directed towards how these interactions dictate virus survival need further investigation. Likewise, in VSV infection, hnRNPA1 was not seen to directly affect viral replication but hnRNPA1 silenced cells displayed delayed onset of virus induced apoptotic events.54 The varied profile of hnRNPA1 in multiple viruses may also appertain to the diverse replication profile exhibited by these viruses. Similar alterations in related viruses may elicit different consequences for viral replication.
Although all these observations are fascinating, many questions pertaining to the functional implication of hnRNPA1 in the host, post‐viral infections, still remain unsolved. Unravelling the complexity and the fate of these hnRNPA1‐virus interactions not only enhances our current understanding of the disease biology and pathogenesis but also helps identify crucial nodal points which can be exploited further. Additionally, it will be imperative to utilize the interactions between viral proteins and hnRNPA1 as tools to identify biomarkers for diagnostic measures and host‐based therapeutics.
CONFLICT OF INTERESTS
The authors declare no conflict of interests.
Kaur R, Lal SK. The multifarious roles of heterogeneous ribonucleoprotein A1 in viral infections. Rev Med Virol. 2020;30:e2097 10.1002/rmv.2097
REFERENCES
- 1. Lamb RA. Krug RM. Orthomyxovirisae: The Viruses and Their Replication. Lippincott‐Raven Press; 1996. [Google Scholar]
- 2. Müller KH, Kakkola L, Nagaraj AS, Cheltsov AV, Anastasina M, Kainov DE. Emerging cellular targets for influenza antiviral agents. Trends Pharmacol Sci. 2012;33(2):89‐99. 10.1016/j.tips.2011.10.004. [DOI] [PubMed] [Google Scholar]
- 3. Vijaykrishna D, Smith GJD, Pybus OG, et al. Long‐term evolution and transmission dynamics of swine influenza A virus. Nature. 2011;473(7348):519‐522. 10.1038/nature10004. [DOI] [PubMed] [Google Scholar]
- 4. Smith GJD, Bahl J, Vijaykrishna D, et al. Dating the emergence of pandemic influenza viruses. Proc Natl Acad Sci. 2009;106(28):11709‐11712. 10.1073/pnas.0904991106. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Chao DL, Bloom JD, Kochin BF, Antia R, Longini IM Jr. The global spread of drug‐resistant influenza. J R Soc Interface. 2012;9(69):648‐656. 10.1098/rsif.2011.0427. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. Hayden FG. Perspectives on antiviral use during pandemic influenza. Philos Trans R Soc London Ser B Biol Sci. 2001;356(1416):1877‐1884. 10.1098/rstb.2001.1007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Chan RWY, Chan MCW, Wong ACN, et al. DAS181 inhibits H5N1 influenza virus infection of human lung tissues. Antimicrob Agents Chemother. 2009;53(9):3935‐3941. 10.1128/AAC.00389-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Edinger TO , Pohl MO, Stertz S. Entry of influenza A virus: host factors and antiviral targets. J Gen Virol. 2014;95(Pt_2):263‐277. 10.1099/vir.0.059477-0. [DOI] [PubMed] [Google Scholar]
- 9. Lee SM‐Y, Yen H‐L. Targeting the host or the virus: current and novel concepts for antiviral approaches against influenza virus infection. Antiviral Res. 2012;96(3):391‐404. 10.1016/j.antiviral.2012.09.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Watanabe T, Kawaoka Y. Influenza virus‐host interactomes as a basis for antiviral drug development. Curr Opin Virol. 2015;14:71‐78. 10.1016/j.coviro.2015.08.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Watanabe T, Watanabe S, Kawaoka Y. Cellular networks involved in the influenza virus life cycle. Cell Host Microbe. 2010;7(6):427‐439. 10.1016/j.chom.2010.05.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Brass AL, Dykxhoorn DM, Benita Y, et al. Identification of host proteins required for HIV infection through a functional genomic screen. Science (80‐ ). 2008;319(5865):921‐926. 10.1126/science.1152725. [DOI] [PubMed] [Google Scholar]
- 13. Brass AL, Huang I‐C, Benita Y, et al. The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus. Cell. 2009;139(7):1243‐1254. 10.1016/j.cell.2009.12.017. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. Cherry S, Doukas T, Armknecht S, et al. Genome‐wide RNAi screen reveals a specific sensitivity of IRES‐containing RNA viruses to host translation inhibition. Genes Dev. 2005;19(4):445‐452. 10.1101/gad.1267905. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Shapira SD, Gat‐Viks I, Shum BOV, et al. A physical and regulatory map of host‐influenza interactions reveals pathways in H1N1 infection. Cell. 2009;139(7):1255‐1267. 10.1016/j.cell.2009.12.018. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. Wang Y, Zhang X. The nucleocapsid protein of coronavirus mouse hepatitis virus interacts with the cellular heterogeneous nuclear ribonucleoprotein A1 in vitro and in vivo. Virology. 1999;265(1):96‐109. 10.1006/viro.1999.0025. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17. Jean‐Philippe J, Paz S, Caputi M. hnRNP A1: the Swiss army knife of gene expression. Int J Mol Sci. 2013;14(9):18999‐19024. 10.3390/ijms140918999. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Lin J‐Y, Shih S‐R, Pan M, et al. hnRNP A1 interacts with the 5′ untranslated regions of enterovirus 71 and Sindbis virus RNA and is required for viral replication. J Virol. 2009;83(12):6106‐6114. 10.1128/JVI.02476-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Katoh H, Mori Y, Kambara H, et al. Heterogeneous nuclear ribonucleoprotein A2 participates in the replication of Japanese encephalitis virus through an interaction with viral proteins and RNA. J Virol. 2011;85(21):10976‐10988. 10.1128/JVI.00846-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Pelisch F, Khauv D, Risso G, et al. Involvement of hnRNP A1 in the matrix metalloprotease‐3‐dependent regulation of Rac1 pre‐mRNA splicing. J Cell Biochem. 2012;113(7):2319‐2329. 10.1002/jcb.24103. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. Roy R, Huang Y, Seckl MJ, Pardo OE. Emerging roles of hnRNPA1 in modulating malignant transformation. Wiley Interdiscip Rev RNA. 2017;8(6):e1431 10.1002/wrna.1431. [DOI] [PubMed] [Google Scholar]
- 22. van der Houven van Oordt W, Diaz‐Meco MT, Lozano J, Krainer AR, Moscat J, Cáceres JF . The Mkk 3/6 ‐p38–signaling cascade alters the subcellular distribution of Hnrnp A1 and modulates alternative splicing regulation. J Cell Biol. 2000;149(2):307‐316. 10.1083/jcb.149.2.307. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23. Fridell RA, Truant R, Thorne L, Benson RE, Cullen BR. Nuclear import of hnRNP A1 is mediated by a novel cellular cofactor related to karyopherin‐β. J Cell Sci. 1997;110(Pt 11):1325‐1331. [DOI] [PubMed] [Google Scholar]
- 24. Bonifaci N, Moroianu J, Radu A, Blobel G. Karyopherin β2 mediates nuclear import of a mRNA binding protein. Proc Natl Acad Sci U S A. 1997;94(10):5055‐5060. 10.1073/pnas.94.10.5055. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25. Roth S, Khalaila I. The effect of O ‐GlcNAcylation on hnRNP A1 translocation and interaction with transportin1. Exp Cell Res. 2017;350(1):210‐217. 10.1016/j.yexcr.2016.11.023. [DOI] [PubMed] [Google Scholar]
- 26. Kim S, Merrill BM, Rajpurohit R, et al. Identification of N G‐methylarginine residues in human heterogeneous RNP protein A1: Phe/Gly‐Gly‐Gly‐Arg‐Gly‐Gly‐Gly/Phe is a preferred recognition motif † . Biochemistry. 1997;36(17):5185‐5192. 10.1021/bi9625509. [DOI] [PubMed] [Google Scholar]
- 27. Rajpurohit R, Paik WK, Kim S. Effect of enzymic methylation of heterogeneous ribonucleoprotein particle A1 on its nucleic‐acid binding and controlled proteolysis. Biochem J. 1994;304(Pt 3):903‐909. 10.1042/bj3040903. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28. Shen EC, Henry MF, Weiss VH, Valentini SR, Silver PA, Lee MS. Arginine methylation facilitates the nuclear export of hnRNP proteins. Genes Dev. 1998;12(5):679‐691. 10.1101/gad.12.5.679. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29. Municio MM, Lozano J, Sánchez P, Moscat J, Diaz‐Meco MT. Identification of heterogeneous ribonucleoprotein A1 as a novel substrate for protein kinase C ζ. J Biol Chem. 1995;270(26):15884‐15891. 10.1074/jbc.270.26.15884. [DOI] [PubMed] [Google Scholar]
- 30. Allemand E, Guil S, Myers M, Moscat J, Caceres JF, Krainer AR. Regulation of heterogenous nuclear ribonucleoprotein A1 transport by phosphorylation in cells stressed by osmotic shock. Proc Natl Acad Sci. 2005;102(10):3605‐3610. 10.1073/pnas.0409889102. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31. Roy R, Durie D, Li H, et al. hnRNPA1 couples nuclear export and translation of specific mRNAs downstream of FGF‐2/S6K2 signalling. Nucleic Acids Res. 2014;42(20):12483‐12497. 10.1093/nar/gku953. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32. Hart GW, Housley MP, Slawson C. Cycling of O‐linked β‐N‐acetylglucosamine on nucleocytoplasmic proteins. Nature. 2007;446(7139):1017‐1022. 10.1038/nature05815. [DOI] [PubMed] [Google Scholar]
- 33. Garcia‐Moreno M, Noerenberg M, Ni S, et al. System‐wide profiling of RNA‐binding proteins uncovers key regulators of virus infection. Mol Cell. 2019;74(1):196‐211.e11. 10.1016/j.molcel.2019.01.017. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34. Garcia‐Moreno M, Järvelin AI, Castello A. Unconventional RNA‐binding proteins step into the virus‐host battlefront. Wiley Interdiscip Rev RNA. 2018;9(6):e1498 10.1002/wrna.1498. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35. Lloyd RE. Nuclear proteins hijacked by mammalian cytoplasmic plus strand RNA viruses. Virology. 2015;479‐480:457‐474. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36. Kress E, Baydoun H, Bex F, Gazzolo L, Duc Dodon M. Critical role of hnRNP A1 in HTLV‐1 replication in human transformed T lymphocytes. Retrovirology. 2005;2(1):8 10.1186/1742-4690-2-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37. Gui H, Lu C‐W, Adams S, Stollar V, Li M‐L. hnRNP A1 interacts with the genomic and subgenomic RNA promoters of Sindbis virus and is required for the synthesis of G and SG RNA. J Biomed Sci. 2010;17(1):59 10.1186/1423-0127-17-59. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38. Li Z, Zeng W, Ye S, et al. Cellular hnRNP A1 interacts with nucleocapsid protein of porcine epidemic diarrhea virus and impairs viral replication. Viruses. 2018;10(3):127 10.3390/v10030127. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39. Levengood JD, Tolbert M, Li M‐L, Tolbert BS. High‐affinity interaction of hnRNP A1 with conserved RNA structural elements is required for translation and replication of enterovirus 71. RNA Biol. 2013;10(7):1136‐1145. 10.4161/rna.25107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40. Cammas A, Pileur F, Bonnal S, et al. Cytoplasmic relocalization of heterogeneous nuclear ribonucleoprotein a1 controls translation initiation of specific mRNAs. Mol Biol Cell. 2007;18(12):5048‐5059. 10.1091/mbc.e07-06-0603. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41. Courteau L, Crasto J, Hassanzadeh G, et al. Hexokinase 2 controls cellular stress response through localization of an RNA‐binding protein. Cell Death Dis. 2015;6(8):e1837 10.1038/cddis.2015.209. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42. Chiu H‐C, Huang W, Wang Y‐Y, et al. Heterogeneous nuclear ribonucleoprotein A1 and lamin A/C modulate nucleocytoplasmic shuttling of avian reovirus p17. J Virol. 2019;93(20):e00851‐19 10.1128/JVI.00851-19. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43. Monette A, Ajamian L, López‐Lastra M, Mouland AJ. Human immunodeficiency virus type 1 (HIV‐1) induces the cytoplasmic retention of heterogeneous nuclear ribonucleoprotein A1 by disrupting nuclear import. J Biol Chem. 2009;284(45):31350‐31362. 10.1074/jbc.M109.048736. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44. Zahler AM, Damgaard CK, Kjems J, Caputi M. SC35 and heterogeneous nuclear ribonucleoprotein A/B proteins bind to a juxtaposed exonic splicing enhancer/exonic splicing silencer element to regulate HIV‐1 tat Exon 2 splicing. J Biol Chem. 2004;279(11):10077‐10084. 10.1074/jbc.M312743200. [DOI] [PubMed] [Google Scholar]
- 45. Caputi M, Mayeda A, Krainer AR, Zahler AM. hnRNP A/B proteins are required for inhibition of HIV‐1 pre‐mRNA splicing. EMBO J. 1999;18(14):4060‐4067. 10.1093/emboj/18.14.4060. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46. Jean‐Philippe J, Paz S, Lu ML, Caputi M. A truncated hnRNP A1 isoform, lacking the RGG‐box RNA binding domain, can efficiently regulate HIV‐1 splicing and replication. Biochim Biophys Acta. 2014;1839(4):251‐258. 10.1016/j.bbagrm.2014.02.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47. Hussain S, Perlman S, Gallagher TM. Severe acute respiratory syndrome coronavirus protein 6 accelerates murine hepatitis virus infections by more than one mechanism. J Virol. 2008;82(14):7212‐7222. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48. Jiang X‐S, Tang L‐Y, Dai J, et al. Quantitative analysis of severe acute respiratory syndrome (SARS)‐associated coronavirus‐infected cells using proteomic approaches. Mol Cell Proteomics. 2005;4(7):902‐913. 10.1074/mcp.M400112-MCP200. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49. Shen X, Masters PS. Evaluation of the role of heterogeneous nuclear ribonucleoprotein A1 as a host factor in murine coronavirus discontinuous transcription and genome replication. Proc Natl Acad Sci U S A. 2001;98(5):2717‐2722. 10.1073/pnas.031424298. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50. Shi ST, Yu G‐Y, Lai MMC. Multiple type A/B heterogeneous nuclear ribonucleoproteins (hnRNPs) can replace hnRNP A1 in mouse hepatitis virus RNA synthesis. J Virol. 2003;77(19):10584‐10593. 10.1128/jvi.77.19.10584-10593.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51. Maeto CA, Knott ME, Linero FN, Ellenberg PC, Scolaro LA, Castilla V. Differential effect of acute and persistent Junín virus infections on the nucleo‐cytoplasmic trafficking and expression of heterogeneous nuclear ribonucleoproteins type A and B. J Gen Virol. 2011;92(9):2181‐2190. 10.1099/vir.0.030163-0. [DOI] [PubMed] [Google Scholar]
- 52. Kumarasinghe N, Moss WN. Analysis of a structured intronic region of the LMP2 pre‐mRNA from EBV reveals associations with human regulatory proteins and nuclear actin. BMC Res Notes. 2019;12(1):33 10.1186/s13104-019-4070-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53. Lévesque K, Halvorsen M, Abrahamyan L, et al. Trafficking of HIV‐1 RNA is mediated by heterogeneous nuclear ribonucleoprotein A2 expression and impacts on viral assembly. Traffic. 2006;7(9):1177‐1193. 10.1111/J.1600-0854.2006.00461.X. [DOI] [PubMed] [Google Scholar]
- 54. Pettit Kneller EL, Connor JH, Lyles DS. hnRNPs relocalize to the cytoplasm following infection with vesicular stomatitis virus. J Virol. 2009;83(2):770‐780. 10.1128/jvi.01279-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55. Isken O, Baroth M, Grassmann CW, et al. Nuclear factors are involved in hepatitis C virus RNA replication. RNA. 2007;13(10):1675‐1692. 10.1261/rna.594207. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56. Li Z, Nagy PD. Diverse roles of host RNA‐binding proteins in RNA virus replication. RNA Biol. 2011;8(2):305‐315. 10.4161/rna.8.2.15391. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57. King BR, Hershkowitz D, Eisenhauer PL, et al. A map of the arenavirus nucleoprotein‐host protein interactome reveals that Junín virus selectively impairs the antiviral activity of double‐stranded RNA‐activated protein kinase (PKR). J Virol. 2017;91(15):e00763‐17 10.1128/jvi.00763-17. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58. Kim CS, Seol SK, Song O‐K, Park JH, Jang SK. An RNA‐binding protein, hnRNP A1, and a scaffold protein, septin 6, facilitate hepatitis C virus replication. J Virol. 2007;81(8):3852‐3865. 10.1128/JVI.01311-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59. Nakano K, Watanabe T. HTLV‐1 Rex: the courier of viral messages making use of the host vehicle. Front Microbiol. 2012;3:330 10.3389/fmicb.2012.00330. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60. Ríos‐Marco P, Romero‐López C, Berzal‐Herranz A. The cis‐acting replication element of the Hepatitis C virus genome recruits host factors that influence viral replication and translation. Sci Rep. 2016;6:25729 10.1038/srep25729. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61. McCaffrey AP, Ohashi K, Meuse L, et al. Determinants of hepatitis C translational initiation in vitro, in cultured cells and mice. Mol Ther. 2002;5(6):676‐684. 10.1006/mthe.2002.0600. [DOI] [PubMed] [Google Scholar]
- 62. Bung C, Bochkaeva Z, Terenin I, Zinovkin R, Shatsky IN, Niepmann M. Influence of the hepatitis C virus 3′‐untranslated region on IRES‐dependent and cap‐dependent translation initiation. FEBS Lett. 2010;584(4):837‐842. 10.1016/j.febslet.2010.01.015. [DOI] [PubMed] [Google Scholar]
- 63. Tuplin A, Struthers M, Cook J, Bentley K, Evans DJ. Inhibition of HCV translation by disrupting the structure and interactions of the viral CRE and 3′ X‐tail. Nucleic Acids Res. 2015;43(5):2914‐2926. 10.1093/nar/gkv142. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64. Oh JW, Sheu GT, Lai MM. Template requirement and initiation site selection by hepatitis C virus polymerase on a minimal viral RNA template. J Biol Chem. 2000;275(23):17710‐17717. 10.1074/jbc.M908781199. [DOI] [PubMed] [Google Scholar]
- 65. Huang L, Hwang J, Sharma SD, et al. Hepatitis C virus nonstructural protein 5A (NS5A) is an RNA‐binding protein. J Biol Chem. 2005;280(43):36417‐36428. 10.1074/jbc.M508175200. [DOI] [PubMed] [Google Scholar]
- 66. Tingting P, Caiyun F, Zhigang Y, Pengyuan Y, Zhenghong Y. Subproteomic analysis of the cellular proteins associated with the 3′ untranslated region of the hepatitis C virus genome in human liver cells. Biochem Biophys Res Commun. 2006;347(3):683‐691. 10.1016/j.bbrc.2006.06.144. [DOI] [PubMed] [Google Scholar]
- 67. Harris D, Zhang Z, Chaubey B, Pandey VN. Identification of cellular factors associated with the 3′‐nontranslated region of the hepatitis C virus genome. Mol Cell Proteomics. 2006;5(6):1006‐1018. 10.1074/mcp.M500429-MCP200. [DOI] [PubMed] [Google Scholar]
- 68. Lu H, Li W, Noble WS, Payan D, Anderson DC. Riboproteomics of the hepatitis C virus internal ribosomal entry site. 2004;3(5):949‐957. 10.1021/pr0499592. [DOI] [PubMed] [Google Scholar]
- 69. Strauss EG, De Groot RJ, Levinson R, Strauss JH. Identification of the active site residues in the nsP2 proteinase of sindbis virus. Virology. 1992;191(2):932‐940. 10.1016/0042-6822(92)90268-T. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70. Lin J‐Y, Li M‐L, Brewer G. mRNA decay factor AUF1 binds the internal ribosomal entry site of enterovirus 71 and inhibits virus replication. Menéndez‐Arias L. PLoS One. 2014;9(7):e103827 10.1371/journal.pone.0103827. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71. Lin J‐Y, Chen T‐C, Weng K‐F, Chang S‐C, Chen L‐L, Shih S‐R. Viral and host proteins involved in picornavirus life cycle. J Biomed Sci. 2009;16(1):103 10.1186/1423-0127-16-103. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72. Twyffels L, Gueydan C, Kruys V. Transportin‐1 and transportin‐2: protein nuclear import and beyond. FEBS Lett. 2014;588(10):1857‐1868. 10.1016/J.FEBSLET.2014.04.023. [DOI] [PubMed] [Google Scholar]
- 73. Pollard VW, Michael WM, Nakielny S, Siomi MC, Wang F, Dreyfuss G. A novel receptor‐mediated nuclear protein import pathway. Cell. 1996;86(6):985‐994. 10.1016/s0092-8674(00)80173-7. [DOI] [PubMed] [Google Scholar]
- 74. Li C, Wei H, Yu L, et al. Nuclear localization of the p17 protein of avian reovirus is correlated with autophagy induction and an increase in viral replication. Arch Virol. 2015;160(12):3001‐3010. 10.1007/s00705-015-2598-5. [DOI] [PubMed] [Google Scholar]
- 75. Chi PI, Huang WR, Lai IH, Cheng CY, Liu HJ. The p17 nonstructural protein of avian reovirus triggers autophagy enhancing virus replication via activation of phosphatase and tensin deleted on chromosome 10 (PTEN) and AMP‐activated protein kinase (AMPK), as well as dsRNA‐dependent protein kinase (PKR)/eIF2α signaling pathways. J Biol Chem. 2013;288(5):3571‐3584. 10.1074/jbc.M112.390245. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76. Huang W‐R, Chiu H‐C, Liao T‐L, Chuang K‐P, Shih W‐L, Liu H‐J. Avian reovirus protein p17 functions as a nucleoporin Tpr suppressor leading to activation of p53, p21 and PTEN and inactivation of PI3K/AKT/mTOR and ERK signaling pathways. Yan C. PLoS One. 2015;10(8):e0133699 10.1371/journal.pone.0133699. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 77. de Breyne S, Ohlmann T. Focus on translation initiation of the HIV‐1 mRNAs. Int J Mol Sci. 2018;20(1):E101 10.3390/ijms20010101. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 78. Tange TO , Damgaard CK, Guth S, Valcárcel J, Kjems J. The hnRNP A1 protein regulates HIV‐1 tat splicing via a novel intron silencer element. EMBO J. 2001;20(20):5748‐5758. 10.1093/emboj/20.20.5748. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 79. Zhu J, Mayeda A, Krainer AR. Exon identity established through differential antagonism between exonic splicing silencer‐bound hnRNP A1 and enhancer‐bound SR proteins. Mol Cell. 2001;8(6):1351‐1361. [DOI] [PubMed] [Google Scholar]
- 80. Jablonski JA, Caputi M. Role of cellular RNA processing factors in human immunodeficiency virus type 1 mRNA metabolism, replication, and infectivity. J Virol. 2009;83(2):981‐992. 10.1128/JVI.01801-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 81. Luo H, Chen Q, Chen J, Chen K, Shen X, Jiang H. The nucleocapsid protein of SARS coronavirus has a high binding affinity to the human cellular heterogeneous nuclear ribonucleoprotein A1. FEBS Lett. 2005;579(12):2623‐2628. 10.1016/j.febslet.2005.03.080. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 82. Furuya T, Lai MM. Three different cellular proteins bind to complementary sites on the 5′‐end‐positive and 3′‐end‐negative strands of mouse hepatitis virus RNA. J Virol. 1993;67(12):7215‐7222. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 83. Li H‐P, Zhang X, Duncan R, Comai L, Lai MMC. Heterogeneous nuclear ribonucleoprotein A1 binds to the transcription‐regulatory region of mouse hepatitis virus RNA. Proc Natl Acad Sci. 1997;94(18):9544‐9549. 10.1073/pnas.94.18.9544. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 84. Huang P, Lai MM. Heterogeneous nuclear ribonucleoprotein a1 binds to the 3′‐untranslated region and mediates potential 5′‐3′‐end cross talks of mouse hepatitis virus RNA. J Virol. 2001;75(11):5009‐5017. 10.1128/JVI.75.11.5009-5017.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 85. Zhang W, Qiao H, Lv Y, et al. Apigenin inhibits enterovirus‐71 infection by disrupting viral RNA association with trans‐acting factors. PLoS One. 2014;9(10):e110429 10.1371/journal.pone.0110429. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 86. Zhang XM, Lai MM. Regulation of coronavirus RNA transcription is likely mediated by protein‐RNA interactions. Adv Exp Med Biol. 1995;380:515‐521. [DOI] [PubMed] [Google Scholar]
- 87. Shi ST, Huang P, Li HP, Lai MM. Heterogeneous nuclear ribonucleoprotein A1 regulates RNA synthesis of a cytoplasmic virus. EMBO J. 2000;19(17):4701‐4711. 10.1093/emboj/19.17.4701. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 88. Ben‐David Y, Bani MR, Chabot B, De Koven A, Bernstein A. Retroviral insertions downstream of the heterogeneous nuclear ribonucleoprotein A1 gene in erythroleukemia cells: evidence that A1 is not essential for cell growth. Mol Cell Biol. 1992;12(10):4449‐4455. 10.1128/mcb.12.10.4449. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 89. Linero FN, Sepúlveda CS, Giovannoni F, et al. Host cell factors as antiviral targets in arenavirus infection. Viruses. 2012;4(9):1569‐1591. 10.3390/v4091569. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 90. Ellenberg P, Edreira M, Lozano M, Scolaro L. Synthesis and expression of viral antigens in Vero cells persistently infected with Junin virus. Arch Virol. 2002;147(8):1543‐1557. 10.1007/s00705-002-0823-5. [DOI] [PubMed] [Google Scholar]
- 91. Ellenberg P, Edreira M, Scolaro L. Resistance to superinfection of Vero cells persistently infected with Junin virus. Arch Virol. 2004;149(3):507‐522. 10.1007/s00705-003-0227-1. [DOI] [PubMed] [Google Scholar]
- 92. Lewis SM, Veyrier A, Hosszu Ungureanu N, Bonnal S, Vagner S, Holcik M. Subcellular relocalization of a trans‐acting factor regulates XIAP IRES‐dependent translation. Wickens MP, ed Mol Biol Cell. 2007;18(4):1302‐1311. 10.1091/mbc.e06-06-0515. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 93. Zhao TT, Graber TE, Jordan LE, et al. hnRNP A1 regulates UV‐induced NF‐κB signalling through destabilization of cIAP1 mRNA. Cell Death Differ. 2009;16(2):244‐252. 10.1038/cdd.2008.146. [DOI] [PubMed] [Google Scholar]
- 94. Paz I, Kosti I, Ares M Jr, Cline M, Mandel‐Gutfreund Y. RBPmap: a web server for mapping binding sites of RNA‐binding proteins. Nucleic Acids Res. 2014;42(Web Server issue):W361‐W367. 10.1093/NAR/GKU406. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 95. Kajitani N, Schwartz S. RNA binding proteins that control human papillomavirus gene expression. Biomolecules. 2015;5(2):758‐774. 10.3390/biom5020758. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 96. Graham SV, Faizo AAA. Control of human papillomavirus gene expression by alternative splicing. Virus Res. 2017;231:83‐95. 10.1016/j.virusres.2016.11.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 97. Zhao X, Rush M, Schwartz S. Identification of an hnRNP A1‐dependent splicing silencer in the human papillomavirus type 16 L1 coding region that prevents premature expression of the late L1 gene. J Virol. 2004;78(20):10888‐10905. 10.1128/JVI.78.20.10888-10905.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 98. Zhao X, Fay J, Lambkin H, Schwartz S. Identification of a 17‐nucleotide splicing enhancer in HPV‐16 L1 that counteracts the effect of multiple hnRNP A1‐binding splicing silencers. Virology. 2007;369(2):351‐363. 10.1016/j.virol.2007.08.002. [DOI] [PubMed] [Google Scholar]
- 99. Zhao X, Schwartz S. Inhibition of HPV‐16 L1 expression from L1 cDNAs correlates with the presence of hnRNP A1 binding sites in the L1 coding region. Virus Genes. 2008;36(1):45‐53. 10.1007/s11262-007-0174-0. [DOI] [PubMed] [Google Scholar]
- 100. Rosenberger S, Arce JD‐C, Langbein L, Steenbergen RDM, Rosl F. Alternative splicing of human papillomavirus type‐16 E6/E6* early mRNA is coupled to EGF signaling via Erk1/2 activation. Proc Natl Acad Sci. 2010;107(15):7006‐7011. 10.1073/pnas.1002620107. [DOI] [PMC free article] [PubMed] [Google Scholar]
